These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 18572405

  • 1. Discovery of selective and nonpeptidic cathepsin S inhibitors.
    Irie O, Ehara T, Iwasaki A, Yokokawa F, Sakaki J, Hirao H, Kanazawa T, Teno N, Horiuchi M, Umemura I, Gunji H, Masuya K, Hitomi Y, Iwasaki G, Nonomura K, Tanabe K, Fukaya H, Kosaka T, Snell CR, Hallett A.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):3959-62. PubMed ID: 18572405
    [Abstract] [Full Text] [Related]

  • 2. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
    Alper PB, Liu H, Chatterjee AK, Nguyen KT, Tully DC, Tumanut C, Li J, Harris JL, Tuntland T, Chang J, Gordon P, Hollenbeck T, Karanewsky DS.
    Bioorg Med Chem Lett; 2006 Mar 15; 16(6):1486-90. PubMed ID: 16412634
    [Abstract] [Full Text] [Related]

  • 3. 3-Acylamino-azetidin-2-one as a novel class of cysteine proteases inhibitors.
    Zhou NE, Guo D, Thomas G, Reddy AV, Kaleta J, Purisima E, Menard R, Micetich RG, Singh R.
    Bioorg Med Chem Lett; 2003 Jan 06; 13(1):139-41. PubMed ID: 12467634
    [Abstract] [Full Text] [Related]

  • 4. Azepanone-based inhibitors of human cathepsin L.
    Marquis RW, James I, Zeng J, Trout RE, Thompson S, Rahman A, Yamashita DS, Xie R, Ru Y, Gress CJ, Blake S, Lark MA, Hwang SM, Tomaszek T, Offen P, Head MS, Cummings MD, Veber DF.
    J Med Chem; 2005 Nov 03; 48(22):6870-8. PubMed ID: 16250645
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of tetracyclic nonpeptidic biaryl nitrile inhibitors of cathepsin K.
    Setti EL, Venkatraman S, Palmer JT, Xie X, Cheung H, Yu W, Wesolowski G, Robichaud J.
    Bioorg Med Chem Lett; 2006 Aug 15; 16(16):4296-9. PubMed ID: 16750630
    [Abstract] [Full Text] [Related]

  • 6. 4-Amino-2-cyanopyrimidines: novel scaffold for nonpeptidic cathepsin S inhibitors.
    Irie O, Yokokawa F, Ehara T, Iwasaki A, Iwaki Y, Hitomi Y, Konishi K, Kishida M, Toyao A, Masuya K, Gunji H, Sakaki J, Iwasaki G, Hirao H, Kanazawa T, Tanabe K, Kosaka T, Hart TW, Hallett A.
    Bioorg Med Chem Lett; 2008 Aug 15; 18(16):4642-6. PubMed ID: 18662880
    [Abstract] [Full Text] [Related]

  • 7. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
    Tavares FX, Boncek V, Deaton DN, Hassell AM, Long ST, Miller AB, Payne AA, Miller LR, Shewchuk LM, Wells-Knecht K, Willard DH, Wright LL, Zhou HQ.
    J Med Chem; 2004 Jan 29; 47(3):588-99. PubMed ID: 14736240
    [Abstract] [Full Text] [Related]

  • 8. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
    Falgueyret JP, Oballa RM, Okamoto O, Wesolowski G, Aubin Y, Rydzewski RM, Prasit P, Riendeau D, Rodan SB, Percival MD.
    J Med Chem; 2001 Jan 04; 44(1):94-104. PubMed ID: 11141092
    [Abstract] [Full Text] [Related]

  • 9. Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
    Barrett DG, Catalano JG, Deaton DN, Hassell AM, Long ST, Miller AB, Miller LR, Ray JA, Samano V, Shewchuk LM, Wells-Knecht KJ, Willard DH, Wright LL.
    Bioorg Med Chem Lett; 2006 Mar 15; 16(6):1735-9. PubMed ID: 16376075
    [Abstract] [Full Text] [Related]

  • 10. 5-Aminopyrimidin-2-ylnitriles as cathepsin K inhibitors.
    Morley AD, Kenny PW, Burton B, Heald RA, Macfaul PA, Mullett J, Page K, Porres SS, Ribeiro LR, Smith P, Ward S, Wilkinson TJ.
    Bioorg Med Chem Lett; 2009 Mar 15; 19(6):1658-61. PubMed ID: 19231183
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Solid-phase synthesis of a combinatorial array of 1,3-bis(acylamino)-2-butanones, inhibitors of the cysteine proteases cathepsins K and L.
    Yamashita DS, Dong X, Oh HJ, Brook CS, Tomaszek TA, Szewczuk L, Tew DG, Veber DF.
    J Comb Chem; 1999 Mar 15; 1(3):207-15. PubMed ID: 10746010
    [Abstract] [Full Text] [Related]

  • 14. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides.
    Guay J, Falgueyret JP, Ducret A, Percival MD, Mancini JA.
    Eur J Biochem; 2000 Oct 15; 267(20):6311-8. PubMed ID: 11012686
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acyclic cyanamide-based inhibitors of cathepsin K.
    Barrett DG, Deaton DN, Hassell AM, McFadyen RB, Miller AB, Miller LR, Payne JA, Shewchuk LM, Willard DH, Wright LL.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3039-43. PubMed ID: 15896958
    [Abstract] [Full Text] [Related]

  • 17. The consequences of lysosomotropism on the design of selective cathepsin K inhibitors.
    Black WC, Percival MD.
    Chembiochem; 2006 Oct 15; 7(10):1525-35. PubMed ID: 16921579
    [Abstract] [Full Text] [Related]

  • 18. Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K.
    Marquis RW, Ru Y, Yamashita DS, Oh HJ, Yen J, Thompson SK, Carr TJ, Levy MA, Tomaszek TA, Ijames CF, Smith WW, Zhao B, Janson CA, Abdel-Meguid SS, D'Alessio KJ, McQueney MS, Veber DF.
    Bioorg Med Chem; 1999 Apr 15; 7(4):581-8. PubMed ID: 10353637
    [Abstract] [Full Text] [Related]

  • 19. A novel class of nonpeptidic biaryl inhibitors of human cathepsin K.
    Robichaud J, Oballa R, Prasit P, Falgueyret JP, Percival MD, Wesolowski G, Rodan SB, Kimmel D, Johnson C, Bryant C, Venkatraman S, Setti E, Mendonca R, Palmer JT.
    J Med Chem; 2003 Aug 14; 46(17):3709-27. PubMed ID: 12904076
    [Abstract] [Full Text] [Related]

  • 20. 3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity.
    Setti EL, Davis D, Janc JW, Jeffery DA, Cheung H, Yu W.
    Bioorg Med Chem Lett; 2005 Mar 01; 15(5):1529-34. PubMed ID: 15713422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.